Met Life Investment Management, LLC G1 Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.04 - $8.51 $94,572 - $199,210	-23,409 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$7.6 - $11.02 $177,908 - $257,967	23,409 New	23,409 $177,000
Q1 2022 Jun 20, 2023	BUY	$7.6 - $11.02 $177,908 - $257,967	23,409 New	23,409 $177,000
Q1 2022 Mar 22, 2023	BUY	$7.6 - $11.02 $64,220 - $93,119	8,450 Added 56.49%	23,409 $177,000
Q1 2022 May 12, 2022	BUY	$7.6 - $11.02 $64,220 - $93,119	8,450 Added 56.49%	23,409 $178,000
Q4 2021 May 17, 2024	BUY	$10.16 - $16.17 $50,993 - $81,157	5,019 Added 50.49%	14,959 $152,000
Q4 2021 Jun 21, 2023	BUY	$10.16 - $16.17 $151,983 - $241,887	14,959 New	14,959 $152,000
Q4 2021 Mar 22, 2023	BUY	$10.16 - $16.17 $50,993 - $81,157	5,019 Added 50.49%	14,959 $152,000
Q4 2021 Feb 15, 2022	BUY	$10.16 - $16.17 $50,993 - $81,157	5,019 Added 50.49%	14,959 $153,000
Q3 2021 May 17, 2024	SELL	$13.16 - $22.47 $75,722 - $129,292	-5,754 Reduced 36.66%	9,940 $133,000
Q3 2021 Jun 21, 2023	BUY	$13.16 - $22.47 $130,810 - $223,351	9,940 New	9,940 $133,000
Q3 2021 Mar 22, 2023	SELL	$13.16 - $22.47 $75,722 - $129,292	-5,754 Reduced 36.66%	9,940 $133,000
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $75,722 - $129,292	-5,754 Reduced 36.66%	9,940 $133,000
Q2 2021 Jun 21, 2023	BUY	$19.57 - $26.32 $307,131 - $413,066	15,694 New	15,694 $344,000
Q1 2021 May 17, 2024	BUY	$17.58 - $32.59 $275,900 - $511,467	15,694 New	15,694 $377,000
Q1 2021 Jun 26, 2023	BUY	$17.58 - $32.59 $275,900 - $511,467	15,694 New	15,694 $378 Million
Q4 2020 Jun 22, 2023	BUY	$10.99 - $20.4 $172,477 - $320,157	15,694 New	15,694 $282,000
Q3 2020 Jun 26, 2023	BUY	$11.55 - $23.75 $181,265 - $372,732	15,694 New	15,694 $181,000
Q2 2020 May 24, 2024	BUY	$9.57 - $24.37 $150,191 - $382,462	15,694 New	15,694 $381 Million
Q2 2020 Jun 26, 2023	BUY	$9.57 - $24.37 $150,191 - $382,462	15,694 New	15,694 $380,000
Q1 2020 Jul 12, 2023	BUY	$9.07 - $26.32 $142,344 - $413,066	15,694 New	15,694 $172,000
Q4 2019 Jul 12, 2023	BUY	$20.54 - $31.0 $322,354 - $486,514	15,694 New	15,694 $414,000
Q3 2019 Jul 12, 2023	BUY	$22.78 - $40.58 $357,509 - $636,862	15,694 New	15,694 $357,000
Q3 2019 Mar 22, 2023	BUY	$22.78 - $40.58 $137,568 - $245,062	6,039 Added 62.55%	15,694 $357,000
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $137,568 - $245,062	6,039 Added 62.55%	15,694 $358,000
Q2 2019 Jul 12, 2023	BUY	$16.03 - $31.1 $251,574 - $488,083	15,694 New	15,694 $481,000
Q1 2019 Jul 13, 2023	BUY	$14.4 - $21.45 $139,032 - $207,099	9,655 New	9,655 $160,000
Q4 2018 Jul 13, 2023	BUY	$16.51 - $51.33 $159,404 - $495,591	9,655 New	9,655 $184,000
Q4 2018 Mar 22, 2023	SELL	$16.51 - $51.33 $87,915 - $273,332	-5,325 Reduced 35.55%	9,655 $184,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $87,915 - $273,332	-5,325 Reduced 35.55%	9,655 $185,000
Q3 2018 Jul 13, 2023	BUY	$43.15 - $67.97 $416,613 - $656,250	9,655 New	9,655 $504,000
Q3 2018 Mar 22, 2023	BUY	$43.15 - $67.97 $646,387 - $1.02 Million	14,980 New	14,980 $783,000
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $229,773 - $361,940	5,325 Added 55.15%	14,980 $783,000
Q2 2018 Aug 15, 2018	BUY	$35.06 - $51.17 $109,492 - $159,803	3,123 Added 47.81%	9,655 $420,000
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $124,434 - $272,776	6,532 New	6,532 $242,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account